Trials / Completed
CompletedNCT03597113
Evaluation of Infants Fed an Extensively Hydrolyzed Hypo Allergenic Infant Formula
Growth and Compliance of Infants Fed an Extensively Hydrolyzed Hypo Allergenic Infant Formula
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 320 (actual)
- Sponsor
- Abbott Nutrition · Industry
- Sex
- All
- Age
- 0 Days – 180 Days
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the growth and compliance of an intended use population of infants receiving an extensively hydrolyzed infant formula.
Conditions
Timeline
- Start date
- 2018-01-31
- Primary completion
- 2020-03-27
- Completion
- 2020-03-27
- First posted
- 2018-07-24
- Last updated
- 2021-03-03
Locations
46 sites across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT03597113. Inclusion in this directory is not an endorsement.